PLD4 (Phospholipase D family member 4) is a type II transmembrane glycoprotein that, despite its name, functions as a 5'-to-3' exonuclease rather than a classical phospholipase. It is highly expressed in plasmacytoid dendritic cells, microglia, and other myeloid lineage cells. PLD4 localizes to endolysosomes where it degrades single-stranded DNA and RNA, thereby limiting activation of nucleic acid-sensing Toll-like receptors (TLR7, TLR9) and preventing autoinflammatory responses. Recent work (2024) has also demonstrated that PLD4 synthesizes S,S-bis(monoacylglycero)phosphate (BMP), a key lysosomal lipid essential for lipid catabolism. PLD4 is associated with autoimmune disease susceptibility including systemic lupus erythematosus, rheumatoid arthritis, and systemic sclerosis.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
| GO:0012505 endomembrane system | IBA GO_REF:0000033 | ACCEPT | Summary: PLD4 is a type II transmembrane protein that traffics through the endomembrane system to reach endolysosomes. IBA annotation based on phylogenetic inference is consistent with localization data from structural and biochemical studies. Reason: PLD4 is synthesized as a type II membrane protein with an N-terminal cytosolic tail and luminal catalytic domain that traffics through the endomembrane system to endolysosomes. This is well-supported by the IBA inference. Supporting Evidence: file:human/PLD4/PLD4-deep-research-falcon.md PLD4 is a type II transmembrane protein localized to the endoplasmic reticulum, Golgi apparatus, and endolysosomal compartments. |
| GO:0006909 phagocytosis | IBA GO_REF:0000033 | KEEP AS NON CORE | Summary: PLD4 has been linked to phagocytosis in microglia. Reason: While PLD4 is involved in phagocytosis via its role in processing phagocytosed material in the endolysosomal pathway, this is not its core molecular function. The primary functions are exonuclease activity and S,S-BMP synthesis. Supporting Evidence: file:human/PLD4/PLD4-deep-research-falcon.md PLD4 mRNA was expressed in microglial cells in early postnatal mouse brains. |
| GO:0002376 immune system process | IEA GO_REF:0000043 | MODIFY | Summary: PLD4 plays a critical role in immune regulation by degrading nucleic acids in endolysosomes, thereby limiting TLR7/TLR9 activation. Reason: This term is too general. PLD4 specifically regulates innate immune responses by degrading TLR ligands. More specific terms like innate immune response (GO:0045087) better capture PLD4's function. Proposed replacements: innate immune response regulation of cytokine production involved in inflammatory response Supporting Evidence: PMID:30111894 PLD3 and PLD4 are single-stranded acid exonucleases that regulate endosomal nucleic-acid sensing. |
| GO:0003824 catalytic activity | IEA GO_REF:0000002 | MODIFY | Summary: PLD4 has catalytic activity - specifically 5'-3' exonuclease activity and S,S-BMP synthase activity. Reason: This term is too general to be useful. PLD4's specific catalytic activity is single-stranded DNA 5'-3' exonuclease activity (GO:0045145). Proposed replacements: single-stranded DNA 5'-3' DNA exonuclease activity Supporting Evidence: PMID:30111894 PLD3 and PLD4 are single-stranded acid exonucleases that regulate endosomal nucleic-acid sensing. |
| GO:0004518 nuclease activity | IEA GO_REF:0000043 | MODIFY | Summary: PLD4 has nuclease activity, specifically 5'-3' exonuclease activity on ssDNA and ssRNA. Reason: While PLD4 does have nuclease activity, the more specific term GO:0045145 (single-stranded DNA 5'-3' exonuclease activity) better describes its actual enzymatic function. Proposed replacements: single-stranded DNA 5'-3' DNA exonuclease activity Supporting Evidence: PMID:38537643 The enzymes digest ssDNA and ssRNA in a 5'-to-3' manner and are blocked by 5'-phosphorylation. |
| GO:0004527 exonuclease activity | IEA GO_REF:0000043 | MODIFY | Summary: PLD4 is indeed an exonuclease, specifically a 5'-3' exonuclease. Reason: While accurate, the more specific term GO:0045145 (single-stranded DNA 5'-3' exonuclease activity) is preferred as it captures the directionality and substrate specificity of PLD4. Proposed replacements: single-stranded DNA 5'-3' DNA exonuclease activity Supporting Evidence: PMID:38537643 The enzymes digest ssDNA and ssRNA in a 5'-to-3' manner and are blocked by 5'-phosphorylation. |
| GO:0005634 nucleus | IEA GO_REF:0000120 | KEEP AS NON CORE | Summary: Nuclear localization of PLD4 is reported based on orthology to mouse PLD4. Reason: Nuclear localization appears to be a resting state in certain cell types. The primary functional location is the endolysosomal system where PLD4 performs its exonuclease and BMP synthase activities. Supporting Evidence: file:human/PLD4/PLD4-deep-research-falcon.md PLD4 is a type II transmembrane protein localized to the endoplasmic reticulum, Golgi apparatus, and endolysosomal compartments. |
| GO:0005764 lysosome | IEA GO_REF:0000044 | ACCEPT | Summary: Lysosomal localization is a core feature of PLD4. It performs both its exonuclease activity and S,S-BMP synthesis in the lysosomal lumen at acidic pH. Reason: Lysosomal localization is directly demonstrated in Singh et al. 2024 (Cell) and is essential for PLD4's functions, which are optimized for acidic pH. Supporting Evidence: PMID:39423811 PLD3 and PLD4 synthesize S,S-BMP, a key phospholipid enabling lipid degradation in lysosomes. |
| GO:0005768 endosome | IEA GO_REF:0000117 | ACCEPT | Summary: PLD4 localizes to endosomes as part of the endolysosomal pathway. Reason: Endosomal localization is consistent with PLD4's role in degrading nucleic acids that enter via endocytosis and its function in regulating TLR signaling. Supporting Evidence: PMID:30111894 PLD3 and PLD4 are single-stranded acid exonucleases that regulate endosomal nucleic-acid sensing. |
| GO:0005769 early endosome | IEA GO_REF:0000120 | ACCEPT | Summary: Early endosome localization is supported by orthology to mouse PLD4. Reason: As a type II transmembrane protein, PLD4 traffics through early endosomes to reach its final destination in late endosomes and lysosomes. Supporting Evidence: file:human/PLD4/PLD4-deep-research-falcon.md PLD4 is a type II transmembrane protein localized to the endoplasmic reticulum, Golgi apparatus, and endolysosomal compartments. |
| GO:0005789 endoplasmic reticulum membrane | IEA GO_REF:0000120 | ACCEPT | Summary: ER membrane localization is expected for a type II transmembrane protein during synthesis and initial trafficking. Reason: As a transmembrane glycoprotein, PLD4 is synthesized and inserted into the ER membrane before trafficking to endolysosomes. Supporting Evidence: PMID:21085684 PLD4 protein was localized in organelle membranes, including the ER and Golgi complex. |
| GO:0005794 Golgi apparatus | IEA GO_REF:0000044 | ACCEPT | Summary: Golgi localization is expected as PLD4 is a heavily N-glycosylated transmembrane protein that transits through the Golgi during maturation. Reason: PLD4 has multiple N-glycosylation sites and must transit through the Golgi for glycan processing before reaching endolysosomes. Supporting Evidence: PMID:21085684 PLD4 protein was localized in organelle membranes, including the ER and Golgi complex. |
| GO:0006259 DNA metabolic process | IEA GO_REF:0000108 | ACCEPT | Summary: PLD4 participates in DNA metabolic process through its exonuclease activity that degrades ssDNA. Reason: PLD4 degrades ssDNA as part of its role in clearing nucleic acids from endolysosomes. Supporting Evidence: PMID:30111894 PLD3 and PLD4 are single-stranded acid exonucleases that regulate endosomal nucleic-acid sensing. |
| GO:0006629 lipid metabolic process | IEA GO_REF:0000043 | ACCEPT | Summary: Recent work (Singh et al. 2024) demonstrates that PLD4 synthesizes S,S-BMP, a lysosomal lipid essential for lipid catabolism. Reason: PLD4 catalyzes the transphosphatidylation reaction producing S,S-BMP from lyso-PG and monoacylglycerol. This is a genuine lipid metabolic function. Supporting Evidence: PMID:39423811 PLD3 and PLD4 synthesize S,S-BMP, a key phospholipid enabling lipid degradation in lysosomes. |
| GO:0006954 inflammatory response | IEA GO_REF:0000043 | ACCEPT | Summary: PLD4 regulates inflammatory responses by degrading nucleic acid ligands of TLR7/TLR9, thereby limiting cytokine production. Reason: PLD4 is a negative regulator of inflammation. Mice lacking PLD4 develop spontaneous inflammatory syndrome with splenomegaly and elevated IFN-gamma. Supporting Evidence: PMID:30111894 PLD4-deficient mice were found to have an inflammatory disease, marked by elevated levels of interferon-gamma (IFN-gamma) and splenomegaly. |
| GO:0016787 hydrolase activity | IEA GO_REF:0000043 | MODIFY | Summary: PLD4 has hydrolase activity - it hydrolyzes phosphodiester bonds in nucleic acids. Reason: This term is too general. PLD4 specifically has 5'-3' exonuclease activity on single-stranded nucleic acids. Proposed replacements: single-stranded DNA 5'-3' DNA exonuclease activity Supporting Evidence: PMID:38537643 The enzymes digest ssDNA and ssRNA in a 5'-to-3' manner and are blocked by 5'-phosphorylation. |
| GO:0031410 cytoplasmic vesicle | IEA GO_REF:0000043 | ACCEPT | Summary: PLD4 localizes to cytoplasmic vesicles including endosomes, lysosomes, and phagosomes. Reason: PLD4 is found in multiple cytoplasmic vesicle types. Supporting Evidence: file:human/PLD4/PLD4-deep-research-falcon.md PLD4 is a type II transmembrane protein localized to the endoplasmic reticulum, Golgi apparatus, and endolysosomal compartments. |
| GO:0045087 innate immune response | IEA GO_REF:0000043 | ACCEPT | Summary: PLD4 is a key regulator of innate immune responses by degrading nucleic acid ligands for TLR7/TLR9. Reason: PLD4 plays a central role in regulating innate immune sensing of nucleic acids. Loss of PLD4 leads to hyperactivation of innate immune pathways. Supporting Evidence: PMID:30111894 PLD3 and PLD4 are single-stranded acid exonucleases that regulate endosomal nucleic-acid sensing. |
| GO:0045335 phagocytic vesicle | IEA GO_REF:0000120 | ACCEPT | Summary: PLD4 localizes to phagocytic vesicles where it degrades nucleic acids from phagocytosed material. Reason: PLD4 redistributes to phagosomes containing ingested particles upon microglial activation. Supporting Evidence: file:human/PLD4/PLD4-deep-research-falcon.md PLD4 mRNA was expressed in microglial cells in early postnatal mouse brains. |
| GO:0002244 hematopoietic progenitor cell differentiation | IEA GO_REF:0000107 | UNDECIDED | Summary: This annotation is based on Ensembl orthology transfer from mouse. Reason: The evidence for this annotation is indirect, based on expression patterns and orthology rather than direct functional studies. Supporting Evidence: GO_REF:0000107 Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara. |
| GO:0005783 endoplasmic reticulum | IEA GO_REF:0000107 | ACCEPT | Summary: ER localization is consistent with PLD4 being a transmembrane protein synthesized in the ER before trafficking to endolysosomes. Reason: As a type II transmembrane glycoprotein, PLD4 is synthesized and initially resides in the ER. Supporting Evidence: PMID:21085684 PLD4 protein was localized in organelle membranes, including the ER and Golgi complex. |
| GO:0006909 phagocytosis | IEA GO_REF:0000107 | KEEP AS NON CORE | Summary: This is a duplicate of the IBA annotation for phagocytosis. Reason: Same reasoning as the IBA annotation - phagocytosis is not PLD4's core function but rather a consequence of its localization to phagosomes. Supporting Evidence: file:human/PLD4/PLD4-deep-research-falcon.md PLD4 mRNA was expressed in microglial cells in early postnatal mouse brains. |
| GO:0032588 trans-Golgi network membrane | IEA GO_REF:0000107 | ACCEPT | Summary: Trans-Golgi network localization is expected for a transmembrane protein undergoing glycan processing. Reason: As a highly glycosylated protein, PLD4 transits through the trans-Golgi network during its biosynthetic pathway to endolysosomes. Supporting Evidence: PMID:21085684 PLD4 protein was localized in organelle membranes, including the ER and Golgi complex. |
| GO:0045145 single-stranded DNA 5'-3' DNA exonuclease activity | IEA GO_REF:0000120 | ACCEPT | Summary: This is the core molecular function of PLD4. Multiple studies have directly demonstrated 5'-3' exonuclease activity on ssDNA substrates. Reason: This is the primary enzymatic activity of PLD4, directly demonstrated in biochemical and structural studies. Supporting Evidence: PMID:30111894 PLD4 and PLD3 are single-stranded 5′ exonucleases |
| GO:1900015 regulation of cytokine production involved in inflammatory response | IEA GO_REF:0000107 | ACCEPT | Summary: PLD4 regulates cytokine production by limiting TLR7/TLR9 activation through degradation of their nucleic acid ligands. Reason: PLD4 deficiency leads to elevated cytokine responses to TLR agonists and spontaneous inflammation. Supporting Evidence: PMID:30111894 PLD4-deficient mice were found to have an inflammatory disease, marked by elevated levels of interferon-gamma (IFN-gamma) and splenomegaly. |
| GO:0005789 endoplasmic reticulum membrane | TAS Reactome:R-HSA-1855214 | ACCEPT | Summary: The ER membrane localization is correct for PLD4 as a type II transmembrane protein, though the Reactome pathway context (R-HSA-1855214) incorrectly describes PLD4 function. PLD4 does NOT hydrolyze PI(4,5)P2. Reason: While the Reactome pathway description incorrectly states that PLD4 hydrolyzes PI(4,5)P2, the ER membrane localization itself is accurate. PLD4 is synthesized in the ER before trafficking to endolysosomes. Supporting Evidence: PMID:21085684 PLD4 protein was localized in organelle membranes, including the ER and Golgi complex. |
| GO:0004630 D-type glycerophospholipase activity | ISS NOT GO_REF:0000024 | ACCEPT | Summary: This is a NOT annotation correctly stating that PLD4 does NOT have phospholipase D activity. This is accurate and important to retain. Reason: Despite belonging to the PLD superfamily and containing HKD motifs, PLD4 does not hydrolyze phosphatidylcholine to phosphatidic acid. Supporting Evidence: PMID:21085684 heterologously expressed PLD4 proteins did not exhibit PLD enzymatic activity. |
| GO:0005769 early endosome | ISS GO_REF:0000024 | ACCEPT | Summary: Duplicate of IEA annotation. Early endosome localization is consistent with PLD4's trafficking to endolysosomes. Reason: ISS annotation based on mouse ortholog. PLD4 transits through early endosomes during its trafficking to late endosomes/lysosomes. Supporting Evidence: file:human/PLD4/PLD4-deep-research-falcon.md PLD4 is a type II transmembrane protein localized to the endoplasmic reticulum, Golgi apparatus, and endolysosomal compartments. |
| GO:0045145 single-stranded DNA 5'-3' DNA exonuclease activity | ISS GO_REF:0000024 | ACCEPT | Summary: Duplicate of IEA annotation. This core molecular function is well-supported by direct experimental evidence. Reason: ISS annotation based on mouse ortholog is correct. Supporting Evidence: PMID:38537643 The enzymes digest ssDNA and ssRNA in a 5'-to-3' manner and are blocked by 5'-phosphorylation. |
| GO:1900015 regulation of cytokine production involved in inflammatory response | ISS GO_REF:0000024 | ACCEPT | Summary: Duplicate of IEA annotation. Reason: ISS annotation based on mouse studies where PLD4 deficiency leads to excessive cytokine production in response to TLR agonists. Supporting Evidence: PMID:30111894 PLD4-deficient mice were found to have an inflammatory disease, marked by elevated levels of interferon-gamma (IFN-gamma) and splenomegaly. |
| GO:0005634 nucleus | ISS GO_REF:0000024 | KEEP AS NON CORE | Summary: Duplicate of IEA annotation. Nuclear localization observed in resting microglia with translocation upon activation. Reason: Nuclear localization is observed in resting cells but PLD4 translocates to phagosomes upon activation. The nucleus is not the primary site of PLD4's enzymatic activity. Supporting Evidence: file:human/PLD4/PLD4-deep-research-falcon.md PLD4 is a type II transmembrane protein localized to the endoplasmic reticulum, Golgi apparatus, and endolysosomal compartments. |
| GO:0005789 endoplasmic reticulum membrane | ISS GO_REF:0000024 | ACCEPT | Summary: Duplicate of IEA and TAS annotations. ER membrane is part of the biosynthetic pathway. Reason: ISS annotation based on mouse ortholog. As a transmembrane protein, PLD4 is synthesized in the ER membrane. Supporting Evidence: PMID:21085684 PLD4 protein was localized in organelle membranes, including the ER and Golgi complex. |
| GO:0006909 phagocytosis | ISS GO_REF:0000024 | KEEP AS NON CORE | Summary: Third annotation for phagocytosis. Reason: Same reasoning as other phagocytosis annotations - this is not a core function but reflects PLD4's role in processing phagocytosed material. Supporting Evidence: file:human/PLD4/PLD4-deep-research-falcon.md PLD4 mRNA was expressed in microglial cells in early postnatal mouse brains. |
| GO:0032588 trans-Golgi network membrane | ISS GO_REF:0000024 | ACCEPT | Summary: Duplicate of IEA annotation. Reason: ISS annotation based on mouse ortholog. PLD4 transits through the TGN during its trafficking to endolysosomes. Supporting Evidence: PMID:21085684 PLD4 protein was localized in organelle membranes, including the ER and Golgi complex. |
| GO:0045335 phagocytic vesicle | ISS GO_REF:0000024 | ACCEPT | Summary: Duplicate of IEA annotation. PLD4 localizes to phagocytic vesicles upon cellular activation. Reason: ISS annotation based on mouse studies. Supporting Evidence: file:human/PLD4/PLD4-deep-research-falcon.md PLD4 mRNA was expressed in microglial cells in early postnatal mouse brains. |
Loading supporting content…
Download this section (compressed HTML)Q: What is the relative contribution of PLD4's exonuclease activity versus its BMP synthase activity to autoimmune disease susceptibility?
Q: Does PLD4 have RNA exonuclease activity as a distinct GO annotation?
Experiment: Determine kinetic parameters (Km, kcat) for PLD4's exonuclease activity on DNA versus RNA substrates. This would help distinguish whether DNA or RNA degradation is the primary physiological function.
Experiment: Characterize BMP levels in immune cells from patients with PLD4 variants associated with autoimmune disease. This would help determine whether BMP deficiency contributes to autoimmune pathology in humans with PLD4 variants.
Loading supporting content…
Download this section (compressed HTML)Loading supporting content…
Download this section (compressed HTML)Loading supporting content…
Download this section (compressed HTML)Loading supporting content…
Download this section (compressed HTML)